These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32941004)

  • 1. Discrete Coiled Coil Rotamers Form within the EGFRvIII Juxtamembrane Domain.
    Mozumdar D; Doerner A; Zhang JY; Rafizadeh DN; Schepartz A
    Biochemistry; 2020 Oct; 59(41):3965-3972. PubMed ID: 32941004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of Allosteric Coupling into and through the Plasma Membrane by EGFR.
    Sinclair JKL; Walker AS; Doerner AE; Schepartz A
    Cell Chem Biol; 2018 Jul; 25(7):857-870.e7. PubMed ID: 29731426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth Factor Identity Is Encoded by Discrete Coiled-Coil Rotamers in the EGFR Juxtamembrane Region.
    Doerner A; Scheck R; Schepartz A
    Chem Biol; 2015 Jun; 22(6):776-84. PubMed ID: 26091170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of the EGFR juxtamembrane domain with PIP2-containing lipid bilayers: Insights from multiscale molecular dynamics simulations.
    Abd Halim KB; Koldsø H; Sansom MSP
    Biochim Biophys Acta; 2015 May; 1850(5):1017-1025. PubMed ID: 25219456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric Inhibition of the Epidermal Growth Factor Receptor.
    Sinclair JKL; Robertson WE; Mozumdar D; Quach K; Schepartz A
    Biochemistry; 2021 Feb; 60(7):500-512. PubMed ID: 33557518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-Protein Interplay in Dimerization of Juxtamembrane Domains of Epidermal Growth Factor Receptor.
    Maeda R; Sato T; Okamoto K; Yanagawa M; Sako Y
    Biophys J; 2018 Feb; 114(4):893-903. PubMed ID: 29490249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural insights into the role and targeting of EGFRvIII.
    Bagchi A; Stayrook SE; Xenaki KT; Starbird CA; Doulkeridou S; El Khoulati R; Roovers RC; Schmitz KR; van Bergen En Henegouwen PMP; Ferguson KM
    Structure; 2024 Sep; 32(9):1367-1380.e6. PubMed ID: 38908376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The juxtamembrane region of the EGF receptor functions as an activation domain.
    Red Brewer M; Choi SH; Alvarado D; Moravcevic K; Pozzi A; Lemmon MA; Carpenter G
    Mol Cell; 2009 Jun; 34(6):641-51. PubMed ID: 19560417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural determinants for membrane binding of the EGFR juxtamembrane domain.
    Wu Z; Li L; Zhu L; Wang R; Dong Y; Zhang Y; Wang Y; Wang J; Zhu L
    FEBS Lett; 2024 Jun; 598(11):1402-1410. PubMed ID: 38589226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between the juxtamembrane domain of the EGFR and calmodulin measured by surface plasmon resonance.
    Aifa S; Johansen K; Nilsson UK; Liedberg B; Lundström I; Svensson SP
    Cell Signal; 2002 Dec; 14(12):1005-13. PubMed ID: 12359306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bipartite tetracysteine display reveals allosteric control of ligand-specific EGFR activation.
    Scheck RA; Lowder MA; Appelbaum JS; Schepartz A
    ACS Chem Biol; 2012 Aug; 7(8):1367-76. PubMed ID: 22667988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of juxtamembrane and transmembrane domains in the mechanism of natriuretic peptide receptor A activation.
    Parat M; Blanchet J; De Léan A
    Biochemistry; 2010 Jun; 49(22):4601-10. PubMed ID: 20214400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ErbB/HER family of protein-tyrosine kinases and cancer.
    Roskoski R
    Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of macrocyclization on allosteric, juxtamembrane-derived, stapled peptide inhibitors of the epidermal growth factor receptor (EGFR).
    Sinclair JK; Schepartz A
    Org Lett; 2014 Sep; 16(18):4916-9. PubMed ID: 25207804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosylation-induced conformational modification positively regulates receptor-receptor association: a study with an aberrant epidermal growth factor receptor (EGFRvIII/DeltaEGFR) expressed in cancer cells.
    Fernandes H; Cohen S; Bishayee S
    J Biol Chem; 2001 Feb; 276(7):5375-83. PubMed ID: 11087732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers.
    Roskoski R
    Pharmacol Res; 2019 Jan; 139():395-411. PubMed ID: 30500458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand binding effects on the activation of the EGFR extracellular domain.
    Shao Q; Zhu W
    Phys Chem Chem Phys; 2019 Apr; 21(15):8141-8151. PubMed ID: 30933195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells.
    Ramnarain DB; Park S; Lee DY; Hatanpaa KJ; Scoggin SO; Otu H; Libermann TA; Raisanen JM; Ashfaq R; Wong ET; Wu J; Elliott R; Habib AA
    Cancer Res; 2006 Jan; 66(2):867-74. PubMed ID: 16424019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to tyrosine kinase inhibition by mutant epidermal growth factor receptor variant III contributes to the neoplastic phenotype of glioblastoma multiforme.
    Learn CA; Hartzell TL; Wikstrand CJ; Archer GE; Rich JN; Friedman AH; Friedman HS; Bigner DD; Sampson JH
    Clin Cancer Res; 2004 May; 10(9):3216-24. PubMed ID: 15131063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of amino acids in the transmembrane and juxtamembrane domains of the platelet-derived growth factor receptor required for productive interaction with the bovine papillomavirus E5 protein.
    Petti LM; Reddy V; Smith SO; DiMaio D
    J Virol; 1997 Oct; 71(10):7318-27. PubMed ID: 9311809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.